Extended Half-life rFVIII for the Treatment of Hemophilia A: Drugs Consumption and Patients’ Perspective. (2020). Farmeconomia. Health Economics and Therapeutic Pathways, 21(1). https://doi.org/10.7175/fe.v21i1.1472